Bio-Techne
TECH
#2271
Rank
S$10.85 B
Marketcap
S$69.36
Share price
-4.80%
Change (1 day)
-20.54%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of December 2025 : S$0.44 Billion

According to Bio-Techne's latest financial reports the company's total debt is S$0.44 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2025-06-30S$0.56 B-0.72%
2024-06-30S$0.56 B-7.61%
2023-06-30S$0.61 B35.75%
2022-06-30S$0.45 B-19.87%
2021-06-30S$0.56 B-6.4%
2020-06-30S$0.60 B-11.52%
2019-06-30S$0.68 B47.8%
2018-06-30S$0.46 B-2.37%
2017-06-30S$0.47 B268.77%
2016-06-30S$0.12 B23.65%
2015-06-30S$0.10 B543.02%
2014-06-30S$16.13 M
2006-06-30S$21.37 M-13.65%
2005-06-30S$24.74 M-8.96%
2004-06-30S$27.18 M-9.39%
2003-06-30S$29.99 M-5.97%
2002-06-30S$31.9 M-7.55%
2001-06-30S$34.51 M0.99%
2000-06-30S$34.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
S$45.19 B 10,068.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
S$24.29 B 5,366.31%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$25.96 B 5,740.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
S$21.35 B 4,703.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
S$2.69 B 506.22%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
S$3.8 M-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S$1.76 B 297.64%๐Ÿ‡บ๐Ÿ‡ธ USA